Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
88 participants
OBSERVATIONAL
2019-01-05
2019-11-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
NCT03940495
Risk Factors of Ectopic Pregnancy
NCT00194207
Incidence of Early Pregnancy Loss in Patients With Unexplained Infertility
NCT01015690
The Levels of the Orexin, Galanin and aMSH and CART in Patients With Hyperemesis Gravidarum
NCT05446025
First Trimester Resistin Levels in HG
NCT06757374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All statistics will be carried out with the use of SPSS (ver. 21, IBM). A P value of \<.05 is considered to be statistically significant. Pearson chi-square test will be used to evaluate between-group differences by pregnancy outcome for categoric data. Kisspeptin differences will be calculated between groups with one way ANOVA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Ectopic pregnancy
blood test
blood test (serum samples) for biochemical examination
Group 2
Early viable pregnancy
blood test
blood test (serum samples) for biochemical examination
Group 3
incomplete miscarriage
blood test
blood test (serum samples) for biochemical examination
Group 4
Healthy women
blood test
blood test (serum samples) for biochemical examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood test
blood test (serum samples) for biochemical examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Women with a molar pregnancy, multiple gestations, gestational age past 6 weeks at the time of blood draw, or if pregnancies were assisted conceptions
18 Years
37 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Semra Yuksel
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Semra Yuksel
Principal investigator, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
sibel bektas, proffessor
Role: STUDY_CHAIR
Gaziosmanpasa Taksim Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziosmanpasa Taksim Education and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GaziosmanpasaTREH20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.